ReviewIntensive care medicine experimental2026
Characterizing heterogeneity and subphenotyping acute respiratory distress syndrome with computed tomography.
Review in Intensive care medicine experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- ARDS management in trauma patients.Intensive care medicine · 2026Review
- Quantitative assessment of lung mechanical properties in ARDS using X-ray computed tomography.Intensive care medicine experimental · 2026Review
- Sex-related differences in lung injury distribution and outcomes in COVID-19 acute respiratory failure: insights from the CT-COVID19 multicenter study group.Intensive care medicine experimental · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Acute respiratory distress syndrome (ARDS) is a heterogeneous clinical syndrome rather than a single disease. Patients who meet the same diagnostic criteria may differ in lung morphology, mechanical properties, biological injury, and clinical course. Current classifications rely largely on the severity of hypoxemia and do not capture this variability, limiting prognostic stratification and individualized treatment. This heterogeneity has clinical consequences. Supportive interventions such as positive end-expiratory pressure (PEEP), prone positioning, and recruitment maneuvers are broadly applied, yet their effects vary substantially among patients. Increasing evidence indicates that these differences are partly explained by variation in lung structure, regional aeration, recruitability, and perfusion. Recent international guidelines have identified phenotyping as a priority in ARDS and have highlighted lung morphology as a relevant source of prognostic enrichment and treatment effect heterogeneity. Computed tomography (CT) provides regional, three-dimensional information on lung injury that is not accessible through bedside physiological measurements. It allows evaluation of aeration loss, lung density, lung weight, and perfusion abnormalities. CT has been used to describe key aspects of lung injury in ARDS and to identify imaging patterns associated with lung mechanics, gas exchange, and response to ventilatory settings. Quantitative and dual-energy CT, together with computational methods, allow a more detailed description of these patterns. This review examines the role of CT in characterizing heterogeneity in ARDS, summarizes qualitative, semi-quantitative, and quantitative approaches, and discusses their clinical relevance and limitations, as well as future directions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.